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A B S T R A C T
Objectives: Invasive disease caused by Neisseria meningitidis is a significant health concern globally, but
our knowledge of the prevailing serogroups, antimicrobial susceptibility patterns, and genetics of N.
meningitidis in Southeast Asia is limited. Chloramphenicol resistance in N. meningitidis has rarely been
reported, but was first described in isolates from Vietnam in 1998. We aimed to characterise eight
chloramphenicol resistant meningococcal isolates collected between 2007 and 2018 from diagnostic
microbiology laboratories in Cambodia, Thailand and the Lao People's Democratic Republic (Laos).
Methods: Whole-genome sequencing was used to generate genome sequences from 18 meningococcal
isolates including the eight chloramphenicol resistant isolates. We identified antimicrobial resistance
genes present in these strains, and examined the phylogenetic relationships between strains.
Results: The eight resistant strains all contain the same chloramphenicol resistance gene first described in
1998, and are closely related to each other. Strains resistant to penicillin, tetracycline, and ciprofloxacin
were also observed, including a chloramphenicol-resistant strain which has acquired penicillin and
ciprofloxacin resistance.
Conclusions: This study suggests that chloramphenicol-resistant N. meningitidis is more widespread than
previously thought, and that the previously-identified resistant lineage is now found in multiple
countries in Southeast Asia.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction
Invasive disease caused by Neisseria meningitidis is an important
global health concern, being associated with significant rates of
mortality and long-term sequelae (Vyse et al., 2013). The burden of
meningococcal disease in Southeast Asia is poorly described, with
few data on prevailing serogroups and antimicrobial susceptibility
patterns (Vyse et al., 2011). The Mahidol-Oxford Tropical Health
Network (MORU) includes diagnostic microbiology laboratories in
Thailand, Laos and Cambodia, where N. meningitidis is an
infrequently isolated pathogen. Detection of a chloramphenicol-
resistant strain of N. meningitidis at our laboratory site in Laos in
November 2017 prompted a review of published reports of
chloramphenicol resistance in N. meningitidis and review of
chloramphenicol susceptibility amongst meningococcal isolates
in our laboratory network. Although no longer standard therapy for
meningococcal meningitis, chloramphenicol is commonly used in
beta-lactam intolerant patients and is recommended as an
alternative agent in international guidelines for treatment of
meningococcal meningitis (Tunkel et al., 2004; McGill et al., 2016),
and therefore resistance to this agent remains an issue of clinical
importance.
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Chloramphenicol resistance in N. meningitidis has rarely been
reported, first being described in 1998 in 11 isolates from Vietnam
and one isolate from France, due to the presence of a chloram-
phenicol transferase gene (catP) possibly derived from a Clostridi-
um perfringens transposable element (Galimand et al., 1998). Two
further isolates with the same catP insertion were later described
in Australia (Shultz et al., 2003) amongst 1382 isolates. More
recently, chloramphenicol resistance was reported in one of 2888
isolates in Brazil (Gorla et al., 2018), and a further highly resistant
isolate was found in Vietnam in 2014 (Tran et al., 2019). Despite
historical use of single-dose oily chloramphenicol for epidemic
management of meningococcal meningitis (Fuller et al., 2003), we
could find no reports of chloramphenicol resistance from Africa,
although susceptibility information on African isolates is limited
(Hedberg et al., 2009).
We identified chloramphenicol resistance in eight of 25
isolates of N. meningitidis in our network laboratories over an
11 year time period. Given the seemingly high frequency of
chloramphenicol resistance amongst our N. meningitidis isolates,
we aimed to characterise the genetic basis of this using whole
genome sequencing. In addition, due to the scarcity of meningo-
coccal data from Southeast Asia, we report serogroup data and
phenotypic and genotypic susceptibilities to other routinely tested
antimicrobial agents in 18 of these isolates that were available for
sequencing.
Methods
Study sites
Clinical isolates from three laboratories were included. The Lao-
Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOM-
WRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos
provides diagnostic microbiology services to Mahosot Hospital as
well as other hospitals in Vientiane and other provincial sites. The
Microbiology Laboratory of the Shoklo Malaria Research Unit
(SMRU), Mae Sot, Thailand supports healthcare provision to
marginalised populations on the Thailand-Myanmar border. The
Cambodia-Oxford Medical Research Unit (COMRU) provides
diagnostic microbiology services to the Angkor Hospital for
Children, a paediatric teaching hospital in Siem Reap, Cambodia.
All laboratories routinely store clinically significant bacterial
isolates at -80 C.
Sample selection, organism identification and phenotypic
antimicrobial susceptibility testing
Laboratory records were reviewed for all clinical isolates of N.
meningitidis up until 31st March 2018, with data available from
year 2000 in LOMWRU, 2007 in SMRU and from 2013 in COMRU. A
total of thirty-four isolates were identified (9 from LOMWRU, 18
from SMRU, 7 from COMRU), of which 25 had susceptibility data for
chloramphenicol and were stored and viable. N. meningitidis
isolates were originally identified by API NH (bioMérieux, France)
and had undergone antimicrobial susceptibility testing (AST) by
disk diffusion for chloramphenicol, ciprofloxacin and ceftriaxone,
and Etest (bioMérieux, France) for penicillin, according to Clinical
and Laboratory Standards Institute (CLSI) standards and break-
points. Before genotypic characterisation, isolates were subcul-
tured on to chocolate agar from storage at 80 C and underwent
confirmation of identity by MALDI-TOF (Vitek MS, bioMérieux) and
AST repeated by Etest (bioMérieux, France) according to manu-
facturer's instructions and CLSI 2018 standards (Wayne, PA, Clinical
and Laboratory Standards Institute 2018). Two isolates failed to
confirm as N. meningitidis, and five were removed as duplicate
isolates from patients in whom N. meningitidis was isolated from
multiple sites, leaving 18 isolates for analysis.
Patient-related metadata
Demographic data, clinical syndrome, antibiotic treatment and
status on discharge were obtained from laboratory records and
patient charts where available.
Genotypic characterization
Sequencing was performed at the MORU laboratories in
Bangkok, Thailand. Libraries were made from extracted DNA using
the Illumina Nextera XT library preparation kit (Illumina, San
Diego, CA, USA) and quantified on an Agilent BioAnalyser (Agilent
Technologies, Santa Clara, CA, USA). The pooled libraries were
sequenced on one run of an Illumina MiSeq sequencer using the v2
reagent kit to give 250 bp paired-end reads. The genome assembly
of chloramphenicol-resistant strain DuyDNT from Vietnam was
obtained from Genbank under accession RPSF00000000.
Spades v3.11.1 (Bankevich et al., 2012) was used to assemble
genomes from whole-genome sequencing. Abricate v0.8.10
Table 1
Clinical information on the samples.
Patient Sample ID Unit Specimen date Sample type Age (years) Sex Diagnosis Antibiotic therapy Status at discharge
1 NM01 SMRU 25/7/07 CSF 7 M Meningitis Unknown Unknown
2 NM03 SMRU 25/11/09 BC 1 F Sepsis Ceftriaxone Well
3 NM04 SMRU 15/11/10 BC <1 M Meningitis Ceftriaxone Well
4 NM06 SMRU 19/6/11 BC 0.2 M Meningitis Unknown Unknown
5 NM07 SMRU 4/10/11 BC 0.5 M Meningitis Ceftriaxone Well
6 NM09 SMRU 7/1/12 BC 0.2 M Meningitis Ceftriaxone Well
7 NM11 SMRU 18/1/12 BC 3 M Meningitis Ceftriaxone Well
8 NM12 SMRU 28/12/12 BC 0.3 F Sepsis Ceftriaxone Well
9 NM13 SMRU 13/5/13 BC 0.6 M Sepsis Ceftriaxone Well
10 NM14 SMRU 15/2/14 BC 0.3 F Sepsis Ceftriaxone Well
11 NM15 SMRU 19/12/14 BC 0.3 M Sepsis Unknown Well
12 NM16 LOMWRU 10/11/17 CSF 60 F Meningitis Ceftriaxone Well
13 NM18 COMRU 13/10/13 BC 0.14 F Meningitis/Sepsis Ceftriaxone Well
14 NM19 COMRU 25/4/14 BC 1.84 F Sepsis Ceftriaxone Well
15 NM20 COMRU 31/3/15 BC 0.91 F Pneumonia/Sepsis Ceftriaxone Well
16 NM21 COMRU 24/7/16 BC 0.07 M Meningitis/Sepsis Unknown Well
17 NM23 COMRU 22/8/17 BC 0.33 F Meningitis Ceftriaxone Well
18 NM25 LOMWRU 21/3/18 BC 0.25 M Meningitis Ceftriaxone Well
SMRU, Shoklo Malaria Research Unit, Mae Sot, Thailand; LOMWRU, Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Vientiane, Laos; COMRU, Cambodia Oxford
Medical Research Unit, Siem Reap, Cambodia.
CSF, cerebrospinal fluid; BC, blood culture.
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(Seemann, 2018a) was used to look for acquired resistance genes
using the bundled ResFinder database (updated 2018-10-02)
(Zankari et al., 2012). BLAST was used to search for specific
antibiotic resistance genes. Prokka 1.13.3 was used to annotate the
assembled genomes.
In silico serogrouping of the isolates was performed by
retrieving the sequences of the genes in the capsule synthesis
region of the capsule that are unique to each serogroup (csb, csc,
csw and csy) for the B, C, W and Y serogroups respectively, and
determining their presence or absence using BLAST to search the
genome assemblies.
Snippy v4.3.6 (Seemann, 2018b) was used to call SNPs against
the MC58 reference genome from raw sequence data and from the
assembled DuyDNT genome. Initial phylogenetic trees were
generated from the core SNP fasta files using IQ-TREE (Nguyen
et al., 2015) under the GTR + F + ASC + R3model which was the best
fit using BIC implemented in ModelFinder (Kalyaanamoorthy et al.,
2017). The initial tree was used as input to Gubbins v2.3.1
(Croucher et al., 2015) to generate a phylogeny accounting for
recombination.
Results
Phenotypic characteristics and patient-related data
Eighteen isolates of N. meningitidis (11 from Thailand, 5 from
Cambodia, 2 from Laos) from 18 patients were included in the
analysis (Table 1). Eight of 18 (44.4%) meningococcal isolates were
resistant to chloramphenicol. Four of the resistant isolates were
collected from Thailand, and two each from Cambodia and Laos. All
isolates were susceptible to ceftriaxone, but 10/18 (55.5%) isolates
had reduced susceptibility to penicillin, including one isolate
which was resistant according to CLSI criteria (Table 2). Phenotypic
ciprofloxacin resistance was detected in two isolates.
Despite COMRU being the only site with a purely paediatric
population, 17/18 patients were children under 8 years old, with a
median age of approximately 4 months (one patient <1 year old with
no recorded date of birth was attributed the age of 1 year for the
purposesofthecalculation).Mostpatientspresentedwithmeningitis
and/or sepsis, all patients with known antibiotic treatment (14/18)
were treated with ceftriaxone, and all of the 16 patients with known
outcome were discharged alive following clinical improvement.
Genotypic characterization
All 18 isolates underwent sequencing. 0.4–2.4 million sequence
reads were obtained from each isolate, giving 42-233X coverage of
the genome. The genomes were assembled in 133-248 contigs,
with a total length of 2,124,885–2,217,307 bp and n50 between
40.4 and 82.5 kb.
We determined the serogroups of the isolates from the genome
assemblies by looking for the presence of the unique capsule
synthesis genes for the B, C, W and Y serogroups which commonly
cause invasive disease (Harrison et al., 2013). Two isolates showed
the presence of the csc gene, indicating they are serogroup C, while
the other 16 isolates, including all the resistant isolates, had the csb
gene, indicating they are serogroup B. No matches for the
serogroup W or Y genes could be found.
We determined the sequence types of the isolates in our sample
set (Table 1). Of the chloramphenicol resistant isolates, five were
ST-1576, one was ST-11005, and two isolates had novel sequence
types (assigned as ST-14487 and ST-14496). ST-1576 and ST-11005
differ only at the gdh locus, and the two novel sequence types also
differ from ST-1576 at only one locus. None of the chloramphenicol
susceptible isolates were from ST-1576 or ST-11005, but they were
from multiple sequence types, including four isolates with novel
sequence types (assigned as ST-14488, ST-14489, ST-14503, and ST-
14507). Two isolates from Thailand were ST-41 and ST-1145, and
one was from ST-32. These sequence types are part of the ST-41/44
and ST-32 hypervirulent clonal complexes commonly seen in
invasive disease (Racloz and Luiz, 2010). The novel ST-14488
sequence type was also part of the ST-41/44 complex. The ST-14503
isolate belonged to the ST-4821 clonal complex previously
associated with an outbreak in China (Peng et al., 2008). The
other isolates could not be assigned to a clonal complex.
By searching for the presence of antimicrobial resistance genes
in the isolates, we identified a 623 bp catP chloramphenicol
transferase gene with the same flanking sequences in all eight
chloramphenicol resistant isolates. It had previously been shown
that a catP gene was present in the highly chloramphenicol-
resistant DuyDNT isolated in Vietnam in 2014, and the same catP
gene and flanking regions also present in this isolate. By alignment
of the region surrounding the catP gene to the MC58 reference
genome, it was determined that the chloramphenicol resistance
gene was found inserted between genes NMB1351 and NMB1352.
Table 2
Antibiotic resistance and genetic data on the samples. Minimum inhibitory concentration for each antibiotic is shown in brackets.
Sample ID Phenotypic antibiotic
susceptibility
Genotypic antibiotic
resistance
PEN phenotype/genotype
discordance
Serogroup MLST Clonal complex
CHL CIP CRO PEN
NM01 R (128) S (0.004) S (<0.016) I (0.125) CHL, PEN B 1487
NM03 S (1) S (0.004) S (<0.016) I (0.25) PEN B 14488 ST-41/44 complex
NM04 S (2) S (0.004) S (<0.016) S (0.064) B 14489
NM06 S (2) S (0.004) S (<0.016) S (0.064) B 32 ST-32 complex
NM07 S (1) R (0.125) S (<0.016) I (0.25) PEN, CIP, TET C 3256
NM09 S (2) S (0.004) S (<0.016) S (0.064) B 5604
NM11 R 128) S (0.004) S (<0.016) S (0.064) CHL B 14496
NM12 R (128) S (0.004) S (<0.016) R (0.5) CHL, PEN B 1576
NM13 R (128) S (0.004) S (<0.016) S (0.064) CHL B 1576
NM14 S (2) S (0.004) S (<0.016) I (0.25) PEN B 1145 ST-41/44 complex
NM15 S (1) S (0.008) S (<0.016) I (0.25) PEN B 41 ST-41/44 complex
NM16 R (32) S 0.032 S (0.002) I (0.125) CHL Yes B 1576
NM18 R (32) R (0.25) S (0.016) I (0.125) CHL, CIP, PEN B 1576
NM19 S (1) S (0.008) S (0.016) S (0.032) C 14503 ST-4821 complex
NM20 R (32) S (0.016) S (0.016) S (0.064) CHL, PEN Yes B 11005
NM21 S (2) S (0.016) S (0.016) S (0.016) B 12811
NM23 S (2) S (0.016) S (0.016) I (0.125) PEN B 14507
NM25 R (32) S (0.004) S (0.002) I (0.25) CHL, PEN B 1576
CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; PEN, penicillin; TET, tetracycline.
S, susceptible; I, intermediate; R, resistant; MIC, minimum inhibitory concentration.
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The catP gene was identical to the catP gene previously reported in
France (Galimand et al., 1998) and a comparison of the sequences
surrounding the insertion show that it was inserted in the same
position in the genome (Supplementary Figure 1). The insertion is
986 bp identical to the Tn4451 transposon from C. perfringens, but
contains only the catP gene and no complete flanking genes.
Ten of our isolates had reduced susceptibility or resistance to
penicillin, including two of the chloramphenicol-resistant isolates
(NM18 and NM25). We extracted the penA gene sequence to look
for the five amino acid changes known to confer reduced
susceptibility to penicillin (Taha et al., 2007). Nine isolates had
all five amino acid changes, while the other nine isolates had none
of the five changes. Concordance between the phenotypic and
genotypic susceptibility was not complete – one isolate (NM16)
with reduced susceptibility phenotypically did not display the
amino acid changes, while one isolate (NM20) with the penA
changes did not show phenotypic reduced susceptibility (Table 2).
The isolate determined to be resistant to penicillin had the same
penA allele as an isolate with only reduced susceptibility. The
blaROB-1 gene is also known to confer penicillin resistance in N.
meningitidis (Tsang et al., 2019), but this gene was not present in
any of our strains.
Isolate NM07 from Thailand was found to contain the
tetracycline resistance gene tetB. NM07 and NM18, carry the gyrA
Thr91 → Ile mutation known to cause ciprofloxacin resistance
(Enríquez et al., 2008; Skoczynska et al., 2008) and are both
phenotypically resistant to ciprofloxacin.
We generated a phylogeny of the 18 genomes from this study
and the previously-reported DuyDNT chloramphenicol-resistant
isolate (Figure 1) after removing recombinant SNPs, as N.
meningitidis is highly recombinogenic (Feil et al., 1999). This
shows that the chloramphenicol-resistant isolates from all four
countries are in a single clade, with the isolates from each country
clustered together within this clade.
Discussion
We describe phenotypic and genotypic characteristics of 18
isolates of N. meningitidis from three countries in Southeast Asia
isolated over an 11 year period. Most strikingly, chloramphenicol
NM07
NM14
NM03
NM15
DuyDNT
NM11
NM01
NM13
NM16
NM25
NM12
NM20
NM18
NM19
NM04
NM06
NM23
NM09
NM21
Chloramphenicol Penicillin Tetracycline Ciprofloxacin
Cambodia
Laos
Thailand
Vietnam
Resistant
Susceptible
Figure 1. A phylogeny of the 19 Neisseria meningitidis strains showing country of origin and resistance genotypes. The phylogeny was generated by Gubbins using RAxML and
the scale bar indicates the number of SNPs.
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resistance, although rarely reported in the literature, was detected
in a higher proportion (44.4%) of isolates compared to studies from
other regions reporting on susceptibilities of large numbers of
isolates, suggesting this is proportionately more common in
Southeast Asia. The identical catP insertion across the isolates in
this study and the previously reported isolates from Vietnam and
Australia suggests that chloramphenicol resistance in N. menin-
gitidis was acquired once in the ST-1576 lineage, and that lineage
has now spread across Southeast Asia.
A high proportion of our isolates (55.5%) displayed reduced
susceptibility to penicillin, 9/10 of which had genetic markers
known to confer reduced penicillin susceptibility. However, a
penicillin-susceptible isolate also carried these genetic markers,
although the MIC in this isolate was close to the intermediate
breakpoint. There may also be further genetic determinants of
resistance in these strains, as we have limited knowledge of N.
meningitidis genomes in Southeast Asia.
We also identified isolates resistant to multiple antibiotics
including an isolate resistant to chloramphenicol and ciprofloxacin
with reduced susceptibility to penicillin, and the DuyDNT isolate is
susceptible to ciprofloxacin but carries a tetracycline resistance
gene. The first reported chloramphenicol resistant N. meningitidis
isolates were susceptible to penicillin, tetracycline, and quinolones
(Galimand et al., 1998), suggesting that this lineage has acquired
resistance to multiple antibiotics during its spread.
Our isolates were predominantly serogroup B, with only two
patients with strains from serogroup C. This is consistent with
previous reports of serogroup B isolates causing sporadic disease in
Thailand (Pancharoen et al., 2000; Borrow et al., 2017) while very
little information is available about common serogroups in Laos
and Cambodia.
Five of the isolates we identified come from hypervirulent clonal
complexes commonly implicated in invasive disease, including the
ST-32 and ST-41/44 clonal complexes involved in multiple epidemics
(Harrison et al., 2009), and the ST-4821 clonal complex first
identified in China in 2003 (Peng et al., 2008). The remaining
thirteen isolates could not be assigned to one of these lineages, and
manyof these isolateswere from novel sequence types. Thissuggests
predominantly sporadic infection arising from the nasopharyngeal
flora rather than an ongoing serogroup B epidemic.
There are several limitations of this study. The study involved
only three sites and a relatively small number of isolates, reflecting
the relative rarity of invasive meningococcal disease in our
populations, giving only a snapshot of the epidemiology across
the region. Furthermore, only culture-positive isolates were
included, which may have underestimated the true number of
cases and selected for more resistant isolates given the seemingly
high prevalence of pre-hospital antibiotic treatment regionally
(Khennavong et al., 2011), although relatively few additional cases
were identified by routine CSF PCR for N. meningitidis in our
laboratories. Nevertheless, our results suggest that resistance to
chloramphenicol is relatively common in meningococcal isolates
from Southeast Asia. This remains clinically important given the
role of chloramphenicol as a common second-line agent for
treatment of meningococcal meningitis. N. meningitidis which is
non-susceptible to third-generation cephalosporins (Deghmane
et al., 2017) has been recently reported in France, with a penA allele
which may have been acquired from Neisseria gonorrhoeae, raising
the possibility that recombination with extensively drug-resistant
N. gonorrhoeae could result in the spread of further drug resistance
in N. meningitidis. Our phenotypic and genotypic characterisation
of isolates from three countries in Southeast Asia will add to the
limited published data of the epidemiology of meningococcal
disease in Southeast Asia, and aid future surveillance of drug-
resistant isolates.
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